In symptomatic CJD, plasma NfL, t‐tau, and GFAP were strongly elevated, each showing excellent discriminative performance (AUCs > 0.93 vs. HCs and > 0.82 vs. FTD). This evidence concerns the gene NEFL and Creutzfeldt Jacob disease.